Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.06% Nasdaq Up0.21%

More On BIT.AX



News & Info


Analyst Coverage


  • Major Holders
  • Insider Transactions
  • Insider Roster


Biotron Ltd. (BIT.AX)

0.11 Up 0.01(10.00%) Apr 24, 2:10AM EDT
Get the big picture on all your investments.
ProfileGet Profile for:
Biotron Ltd.
56 Delhi Road
Suite 19
North Ryde, NSW 2113
Australia - Map
Phone: 61 2 9805 0488
Fax: 61 2 9805 0688

Index Membership:N/A
Full Time Employees:7

Business Summary 

Biotron Limited develops and commercializes novel small molecule antiviral therapeutics targeting Hepatitis C virus (HCV) and HIV-1 in Australia. Its lead drug includes the BIT225, a viroporin inhibitor, which is in Phase 2 clinical trials used for the treatment of HCV and HIV infections. The company also has a portfolio of clinical and preclinical antiviral programs developing drugs targeting HCV, HIV, Dengue virus, and Influenza virus. Biotron Limited is based in North Ryde, Australia.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Biotron Ltd.

Key Executives 
Dr. Michelle Miller BSc, MSc, Ph.D., GCertAppFin (Finsia),
Managing Director and Exec. Director
Mr. Peter James Nightingale BEc, CA, 57
Company Sec.
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in AUD.